NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) —

Juan MonteverdeFounder and managing partner of the collective law firm Monteverde & Associates PC (the “M&A Class Firm”), a nationally rated investment firm top 50 in the 2018-2021 ISS Securities Class Action Services Report and is headquartered at the Empire State Building in New York City, examined:

• Meridian Bioscience, Inc. (Nasdaq: VIVO) in connection with the proposed acquisition by SD Biosensor, Inc. and SJL Partners LLC. Under the terms of the agreement, VIVO shareholders will receive $34.00 in cash for each share they own. Click here for more information: https://www.monteverdelaw.com/case/meridian-bioscience-inc. It’s free and there are no costs or obligations to you.
  
• Aerie Pharmaceuticals, Inc. (Nasdaq: AIR)in connection with the proposed acquisition by Alcon Inc. Under the terms of the agreement, AERI stockholders are expected to receive $15.25 in cash for each share they own. Click here for more information: http://monteverdelaw.com/case/aerie-pharmaceuticals-inc. It’s free and there are no costs or obligations to you.
• CyberOptics Corp. (Nasdaq: CYBE)in connection with the proposed acquisition by Nordson Corp. Under the terms of the agreement, CYBE shareholders are expected to receive $54.00 in cash for each share they own. Click here for more information: https://www.monteverdelaw.com/case/cyberoptics-corp. It’s free and there are no costs or obligations to you.
  
• Gemini Therapeutics, Inc. (Nasdaq: GMTX)regarding the proposed merger with Disc Medicine, Inc. Under the terms of the agreement, GMTX shareholders are expected to own 28% of the newly combined company. Click here for more information: http://monteverdelaw.com/case/gemini-therapeutics-inc. It’s free and there are no costs or obligations to you.

About Monteverde & Associates PC

We are a national securities class action law firm that has recovered millions of dollars and is dedicated to protecting shareholders from corporate wrongdoing. We have been listed…